SGS S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SGSN.SW research report →
Price Chart
About the company
Established in Geneva, Switzerland, in 1878, SGS SA is a prominent global provider specializing in inspection, verification, testing, certification, and quality assurance services. Its extensive operations reach across Europe, Africa, the Middle East, the Americas, and the Asia Pacific, structured into five main divisions: Connectivity & Products, Health & Nutrition, Industries & Environment, Natural Resources, and Knowledge. The company offers a comprehensive suite of services, including laboratory analysis, product scrutiny, consulting, process evaluation, and technical assistance.
- CEO
- Geraldine J. Picaud
- IPO
- 1995
- Employees
- 83,000
- HQ
- Baar, CH
Get TickerSpark's AI analysis on SGSN.SW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $18.31B
- P/E
- 27.16
- Fwd P/E
- 22.46
- PEG
- 0.72
- P/S
- 2.54
- P/B
- 17.93
- EV/EBITDA
- 14.07
- Div Yield
- 3.46%
- Gross Margin
- 37.25%
- Op Margin
- 14.99%
- Net Margin
- 9.20%
- ROE
- 69.50%
- ROIC
- 12.24%
Latest fiscal year · YoY change
- Revenue
- $6.95B+2.2%
- Gross Profit
- $5.97B+2.3%
- Op Income
- $1.01B
- Net Income
- $668.00M+15.0%
- EPS
- $3.48+12.6%
- OCF Growth
- -0.1%
- FCF Growth
- -0.5%
- 52W High
- $98.76
- 52W Low
- $79.90
- 50D MA
- $94.09
- 200D MA
- $90.85
- Beta
- 0.58
- RSI (14)
- 40
- Avg Volume
- 334.90K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
SGS reported a strong first half with CHF 3.7 billion in sales, 5.6% organic growth, higher margins, and management reaffirmed full-year guidance despite Middle East disruption and FX headwinds.· July 24, 2026
- Sales reached CHF 3.7 billion and adjusted operating margin improved to 15.1%, up 20 bps.
- Organic growth was 5.6%; management said it would have been above 6% without the Middle East impact.
- Free cash flow was a record CHF 260 million, up 25% excluding last year’s headquarters disposal proceeds.
- Digital Trust grew 38% and Sustainability (IMPACT NOW) grew 18%, both highlighted as key structural growth drivers.
- ATS integration is on track, with cost synergies and cross-selling already underway; management also completed five additional bolt-on acquisitions.
SGS posted first-half sales of CHF 3.7 billion, with organic growth of 5.6% and constant-currency growth of 13.4% including 7.8% from M&A. Adjusted operating income margin was 15.1%, up 20 basis points, and EPS reached CHF 1.58, up 14.5% excluding the gain on the headquarters disposal baseline. Free cash flow was CHF 260 million, up 25% excluding the prior-year HQ disposal proceeds. By segment, Industries & Environment grew 4.7% organically, Natural Resources 5.5%, Connectivity & Products 6.8%, Health & Nutrition 4.5%, and Business Assurance 7.3%. Management fully confirmed guidance for the year and said the business is on track despite the Middle East situation.
Geraldine Picaud emphasized execution on Strategy 27, with investment in Digital Trust, AI, Sustainability, ATS, and bolt-on acquisitions. She said SGS is positioned around structural growth areas such as cybersecurity, AI assurance, environmental testing, food safety, and energy transition, and argued that the diversified portfolio helps reduce volatility and support resilient growth. Her tone was confident and upbeat, repeatedly saying the company is “well on track” and will continue to create value through organic growth and selective M&A.
Marta Vlatchkova highlighted a “record first half” with CHF 3.7 billion in sales, 15.1% adjusted operating margin, CHF 260 million of free cash flow, and EPS of CHF 1.58. She broke out margin drivers as CHF 39 million from organic growth/efficiency, CHF 42 million from M&A including ATS, and a CHF 35 million FX headwind, while noting restructuring costs were CHF 18 million in H1 and expected to be around CHF 30 million for the full year, within the prior CHF 20 million to CHF 40 million range. She also said net debt/adjusted EBITDA should be around 2.2x at year-end, financial expenses should not rise significantly in H2, and free cash flow typically follows about a 1/3 to 2/3 H1/H2 seasonality.
Analysts focused on ATS margin and synergy contribution, balance sheet effects from acquisitions, restructuring charges tied to the Middle East, North America growth acceleration, and leverage. Management said ATS is well on track, with synergies fully on plan and at least CHF 5 million of cost synergies expected this year, while reiterating that ATS growth is treated as scope, not organic. On restructuring, they said H1 charges were CHF 18 million and the Middle East accounted for about CHF 8 million, with full-year charges still expected to remain within CHF 20 million to CHF 40 million. They also said leverage should trend to about 2.2x at year-end and that the company prefers to stay below 2x on a sustainable basis.
The call presented broad-based growth across most segments, with especially strong momentum in Digital Trust, Sustainability, environmental testing, and North America. Management sounded confident that ATS integration is generating both synergies and cross-selling opportunities, while the bolt-on pipeline remains active. They also said the company can absorb external shocks like the Middle East conflict and still fully confirm guidance.
The Middle East conflict continued to weigh on growth, margins, and restructuring, with management citing roughly 60 bps impact on H1 organic growth and about CHF 8 million of restructuring cost tied to the situation. Europe was softer in several areas, including clinical testing phasing in Pharma, softer Natural Resources volumes, and weaker trade flows in Connectivity & Products. Leverage is higher after ATS, with net debt at CHF 3.9 billion and year-end leverage expected around 2.2x, which leaves less room if the company continues to pursue acquisitions.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 85.4%
- Shares Outstanding
- 197.79M
- Float Shares
- 168.95M
of shares held by institutions
1 13F filers
Held by 1,080 ETFs
Biggest fund positions in SGSN.SW by dollar value.
Our SGSN.SW coverage
Recent articles, reports, and earnings notes.
No research on SGSN.SW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SGSN.SW report →